PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2022.3882023552498-505EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain MetastasisHongsik Kim, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahnhttp://e-crt.org/upload/pdf/crt-2022-388.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2022.388, http://e-crt.org/upload/pdf/crt-2022-388.pdf
Clinical Lung Cancer10.1016/j.cllc.2020.11.0042021224371-375Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in ProgressShun Lu, Ignacio Casarini, Terufumi Kato, Manuel Cobo, Mustafa Özgüroğlu, Rachel Hodge, Toon van der Gronde, Matilde Saggese, Suresh S. Ramalingamhttps://api.elsevier.com/content/article/PII:S1525730420303375?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730420303375?httpAccept=text/plain
Frontiers in Oncology10.3389/fonc.2022.872225202212Case Report: Aumolertinib as Neoadjuvant Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer With Activated EGFR Mutation: Case SeriesShao Feng, Zhang Qiang, Cheng Wanwan, Zeng Zhaozhun, Xie Yuewu, Fang Shencunhttps://www.frontiersin.org/articles/10.3389/fonc.2022.872225/full
OncoTargets and Therapy10.2147/ott.s1298092017Volume 102335-2340The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancerHao Bai, Liwen Xiong, Baohui Hanhttps://www.dovepress.com/getfile.php?fileID=36235, https://www.dovepress.com/getfile.php?fileID=36235
Lung Cancer10.1016/0169-5002(91)91946-919917159Concurrent carboplatin (CBDCA) and Radiotherapy (RT) for unresectable stage III Non-Small Cell Lung Cancer (NSCLC)https://api.elsevier.com/content/article/PII:0169500291919469?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500291919469?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(20)30176-82020139S65Whole brain radiotherapy (WBRT) for surgically unresectable brain metastasis in pretreated patients with extensive stage small cell lung cancer (ES-SCLC)A. Jegannathen, L. Price, G. Selvarajhttps://api.elsevier.com/content/article/PII:S0169500220301768?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500220301768?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)91705-1199410S335-S336Concurrent carboplatin (CBDCA) and radiotherapy (RT) for unresectable stage III (Mo) non-small cell lung cancer (NSCLC)https://api.elsevier.com/content/article/PII:0169500294917051?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294917051?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(97)89579-71996161127Preoperative chemoradiotherapy for stage III unresectable non-small cell lung cancer: Results of a phase II studyhttps://api.elsevier.com/content/article/PII:S0169500297895797?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500297895797?httpAccept=text/plain
Frontiers in Oncology10.3389/fonc.2022.971192202212Pseudo-progression with osimertinib after definitive chemoradiation in unresectable epidermal growth factor receptor mutation positive of stage III non-small cell lung cancer: A case reportFei Ren, Yao Wang, Yongsheng Gao, Xiangjiao Menghttps://www.frontiersin.org/articles/10.3389/fonc.2022.971192/full
Lung Cancer10.1016/j.lungcan.2008.02.003200862135-44EGFR, TTF-1 and Mdm2 expression in stage III non-small cell lung cancer: A positive associationT. Berghmans, C. Mascaux, A. Haller, A.P. Meert, P. Van Houtte, J.P. Sculierhttps://api.elsevier.com/content/article/PII:S0169500208000639?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500208000639?httpAccept=text/plain